Reversible Pulmonary Arterial Hypertension Associated with Interferon-Beta Treatment for Multiple Sclerosis
Interferon (IFN) therapy has an important role in the treatment of multiple sclerosis and chronic hepatitis C infection. A few case reports have described an association between IFN therapy and the development of irreversible pulmonary arterial hypertension (PAH), and it is currently listed as a pos...
Saved in:
Main Authors: | E Gibbons, S Promislow, RA Davies, G Chandy, DJ Stewart, V Contreras-Dominguez, C Pugliese, R Dunne, LM Mielniczuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2015/181535 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01) -
Fasciitis Complicating Subcutaneous Injection of Interferon Beta
by: Curtis L Cooper, et al.
Published: (2000-01-01) -
Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody
by: Yusho Ishii, et al.
Published: (2020-01-01) -
Inhibitory effect of interferon-beta on mouse spleen-derived mast cells
by: S. Konno, et al.
Published: (1993-01-01) -
Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate
by: Marcin Bazylewicz, et al.
Published: (2025-01-01)